feed,title,long_url,short_url
Benzinga,Avidity Biosciences Or Dyne Therapeutics - Read On Raymond James' Rating Skew,https://benzinga.com/analyst-ratings/analyst-color/22/07/28037934/raymond-james-starts-coverage-on-two-targeted-oligo-delivery-focused-firms,https://bit.ly/3awSGKH
